Tutorials › Pattern-Mixture and Selection Models › Missing Data Within a Defined Estimand

The Estimand Framework and Intercurrent Events · Tutorial 395 of 499

Missing Data Within a Defined Estimand

Learn to separate the clinical question defined by an estimand from the missing-outcome problem that arises when its measurements are not recorded.

Intermediate 11 min read

What You'll Learn

  • Define an estimand separately from the indicator that an outcome was recorded
  • Explain why complete-case means may not estimate the target population mean
  • Identify the assumptions needed for conditional adjustment under missing outcomes
  • Calculate transparent bounds for a treatment contrast using a bounded outcome scale
  • Diagnose when response rates or observed-case summaries are insufficient to support a conclusion

The Target and the Measurement Problem

A clinical question may concern the average outcome for every person in a specified population under a specified treatment strategy. In practice, some outcomes may not be recorded. That creates a problem for estimating the target; it does not, by itself, change what the target means. Keeping these two issues separate is essential: otherwise, an analysis can quietly replace the original question with a different one about people whose outcomes happened to be observed.

Suppose \(A\) denotes assigned treatment, \(Y_i(a)\) is the outcome person \(i\) would have under treatment strategy \(a\), and \(R_i\) indicates whether that outcome is recorded, with \(R_i=1\) for recorded and \(R_i=0\) for unrecorded. Assume the outcome is defined for every person in the estimand population under each strategy being compared. For example, the endpoint might be a symptom score at a stated visit under the specified treatment strategies.

Definition: An estimand is the precise target quantity answering the clinical question, including its population, treatment conditions or strategies, outcome variable, handling of intercurrent events, and population-level summary. A missing outcome is a defined outcome whose value was not recorded. The indicator \(R_i\) describes its recording status; it is not part of the estimand unless the clinical question explicitly defines a target among people with a particular recording status.

For an average-outcome treatment contrast, one possible target is

$$ \mu_a = E\{Y_i(a)\}, \qquad \tau = \mu_1-\mu_0. $$

Here, the expectation is over the estimand population. The outcome scale and strategies must already be specified; the notation does not decide whether an outcome after an intercurrent event is meaningful or how that event is handled. The present issue arises once the target outcome is defined: some of its values are unavailable because they were not recorded.

In a randomized trial, assignment can support comparisons between treatment groups, but it does not guarantee that the recorded outcomes represent all assigned participants. The observed mean in arm \(a\),

$$ E(Y\mid A=a,R=1), $$

is a mean among participants whose outcome was recorded in that arm. It is not automatically the target mean \(E\{Y(a)\}\). Consistency links the outcome observed under a participant’s assigned strategy to the corresponding potential outcome; it does not make missing outcomes observed.

Why Missingness Can Change an Estimate

Let \(Y\) denote the defined outcome in one treatment arm. Splitting the population according to recording status gives the identity

$$ E(Y)=P(R=1)E(Y\mid R=1)+P(R=0)E(Y\mid R=0). $$

This follows by writing \(E(Y)=E\{YI(R=1)\}+E\{YI(R=0)\}\), where \(I(\cdot)\) equals 1 when its condition holds and 0 otherwise, and then factoring each term by the probability of its event. The observed data provide information about \(P(R=1)\) and \(E(Y\mid R=1)\). They do not directly provide \(E(Y\mid R=0)\). Unless that missing-group mean can be recovered under defensible assumptions, the full target mean is not identified by the observed mean alone.

For the observed mean to equal the target mean in a treatment arm, a sufficient condition is that recording status is independent of the outcome in that arm: \(R\perp Y\mid A=a\). Under this condition, the recorded and unrecorded groups have the same outcome mean. The condition can fail even when the recording proportion is high, and the direction of bias depends on how outcomes differ between those groups. Similar response proportions across arms do not establish this condition.

A more useful assumption may be that outcome recording is independent of the outcome after conditioning on recorded participant characteristics \(X\): \(R\perp Y\mid A,X\). This is commonly called missing at random conditional on \(A\) and \(X\). It permits the response probability to vary with observed characteristics, as long as there is no remaining dependence on the unrecorded outcome within those groups. If the outcome still predicts its own recording after conditioning on observed information, the assumption fails; this is a missing-not-at-random situation. These labels describe assumptions about the recording process, not different clinical estimands.

Worked Example: What a Complete-Case Contrast Does and Does Not Say

Consider a hypothetical randomized trial with 100 participants assigned to each treatment strategy. At the planned visit, outcomes are recorded for 80 participants in the treatment arm, whose observed mean is 8 points, and for 95 participants in the comparison arm, whose observed mean is 10 points. Higher scores indicate worse symptoms. The target is the difference in average symptom score for all randomized participants under the two specified strategies.

The observed-case means are \(\bar{Y}_{1,\mathrm{obs}}=8\) points and \(\bar{Y}_{0,\mathrm{obs}}=10\) points. Their difference is

$$ \bar{Y}_{1,\mathrm{obs}}-\bar{Y}_{0,\mathrm{obs}} =8-10=-2\text{ points}. $$

This is a difference between the recorded-outcome participants in the two arms. It is not necessarily an estimate of the target contrast \(\tau\), which concerns all 100 participants per arm. For example, if participants with worse symptoms were less likely to provide an outcome in the treatment arm, its observed mean could be too low relative to its target mean. The given counts and means do not tell us whether that happened; the missing outcomes are not summarized by the response rate alone.

The observed outcome proportions are \(80/100=0.80\) in the treatment arm and \(95/100=0.95\) in the comparison arm. These figures reveal unequal completeness, but neither prove nor quantify bias. Without assumptions or additional information about the unrecorded outcomes, the correct conclusion is that the observed contrast is \(-2\) points among recorded cases and its relation to the all-participant target is uncertain.

Recovering the Target Under an Explicit Assumption

When observed characteristics explain differences in recording, conditional adjustment can preserve the original target population. Suppose \(X\) is a baseline risk group, and \(q(x)\) is the proportion of the target population in group \(x\). If, within each treatment arm and group, the mean outcome among recorded participants equals the group’s target mean, then the arm mean can be calculated by standardizing the observed group means to the target population:

$$ \mu_a = \sum_x q(x) E(Y\mid A=a,X=x,R=1). $$

This approach requires the conditional independence assumption \(R\perp Y\mid A,X\), and positivity: each target group must have a nonzero chance of having its outcome recorded in each arm being analyzed. If a group has no recorded outcomes, its mean cannot be estimated from that group’s observed outcomes. Standardization also requires that the chosen \(X\) values and their distribution \(q(x)\) correspond to the target population.

Worked Example: Standardizing Across Baseline Risk Groups

In a hypothetical trial, half the target population is in a lower-risk group and half in a higher-risk group. Outcomes are symptom scores, with higher values worse. The observed group means and response counts are as follows:

ArmRisk groupAssignedRecordedObserved mean
ComparisonLower50454 points
ComparisonHigher50258 points
TreatmentLower50403 points
TreatmentHigher50206 points

Assume, for this calculation, that within each arm and risk group, recording is independent of the outcome, and that every group has a positive recording probability. The observed group means then estimate the corresponding target group means. The target gives each risk group weight 0.50, so the standardized comparison-arm mean is

$$ \hat{\mu}_0 = (0.50)(4)+(0.50)(8)=2+4=6\text{ points}. $$

The standardized treatment-arm mean is

$$ \hat{\mu}_1 = (0.50)(3)+(0.50)(6)=1.5+3=4.5\text{ points}. $$

Thus the estimated target contrast is \(\hat{\tau}=4.5-6=-1.5\) points. This estimate relies on the stated within-group assumption. The raw complete-case means instead weight risk groups by their recorded counts: the comparison mean is \(\{(45)(4)+(25)(8)\}/70=380/70=5.429\) points, and the treatment mean is \(\{(40)(3)+(20)(6)\}/60=240/60=4\) points. Their difference, \(-1.429\) points, answers a different weighted comparison because the recorded participants have different risk-group distributions. Standardization retains the target’s equal group weights, but cannot correct residual outcome-related recording within groups.

Inverse-probability weighting is another way to use observed characteristics: recorded outcomes are weighted to represent participants with similar characteristics whose outcomes were not recorded. Like standardization, it depends on a correctly specified recording model, conditional independence of recording and outcome given the included information, and positivity. Very small estimated response probabilities can produce unstable weights and highly variable estimates. Multiple imputation is another familiar approach, but it likewise needs a model that makes the missing outcomes predictable from observed information and appropriate uncertainty calculations. None of these procedures changes the estimand; each makes assumptions to estimate it.

What Can Be Learned Without a Missingness Assumption?

When an outcome has known lower and upper limits, those limits can give bounds on the target even if the missing outcomes cannot be predicted. The bounds require that every outcome lies within the stated range, but do not require missing outcomes to resemble recorded ones. They may be wide; that width is informative because it shows how much the missing measurements leave unresolved.

Worked Example: Bounding a Treatment Contrast on a Bounded Scale

Suppose a hypothetical symptom score is bounded from 0 to 10 points. In the treatment arm, 80 of 100 participants have recorded outcomes, with mean 7 points. In the comparison arm, 90 of 100 have recorded outcomes, with mean 6 points. Assume only that all unrecorded scores also lie between 0 and 10.

The treatment-arm mean cannot be smaller than if all 20 unrecorded scores were 0, or larger than if they were all 10:

$$ \frac{(80)(7)+(20)(0)}{100} \leq \mu_1 \leq \frac{(80)(7)+(20)(10)}{100}, \qquad 5.6 \leq \mu_1 \leq 7.6\text{ points}. $$

Similarly, the comparison-arm bounds are

$$ \frac{(90)(6)+(10)(0)}{100} \leq \mu_0 \leq \frac{(90)(6)+(10)(10)}{100}, \qquad 5.4 \leq \mu_0 \leq 6.4\text{ points}. $$

The smallest possible treatment-minus-comparison contrast pairs the treatment lower bound with the comparison upper bound; the largest pairs the treatment upper bound with the comparison lower bound. Therefore

$$ 5.6-6.4 \leq \tau \leq 7.6-5.4, \qquad -0.8 \leq \tau \leq 2.2\text{ points}. $$

These are bounds based on the score range and observed data, not a confidence interval. The observed-case contrast is \(7-6=1\) point, but the bounds include contrasts below and above zero. On these assumptions alone, even the direction of the target contrast is not determined.

Diagnostics, Comparisons, and Common Pitfalls

Useful diagnostics begin with describing who has and has not provided an outcome. Report counts and proportions by treatment arm and important observed characteristics, then inspect whether missingness is concentrated in particular groups or visits. Compare observed baseline characteristics and earlier recorded outcomes across recording status. These checks can reveal patterns that challenge a simple complete-case analysis or a proposed conditional model.

However, no comparison of observed variables can prove that outcomes are unrelated to recording after conditioning on those variables. The key diagnostic limitation is that the outcome values for \(R=0\) are unavailable, so the dependence of recording on those values cannot be checked directly. Model-based estimates should therefore be accompanied by a clear account of the assumptions and by sensitivity analyses that examine alternative plausible assumptions. If the result changes substantially across reasonable approaches, the data do not support a robust conclusion without stronger information.

The main approaches answer different practical needs:

  • Complete-case analysis uses recorded outcomes only. It is simple, but targets the recorded cases directly and needs conditions for that result to represent the full target population.
  • Conditional standardization or weighting uses observed characteristics to account for differing recording patterns. It can estimate the original target under conditional independence and positivity, but is vulnerable to omitted predictors, model misspecification, and sparse groups.
  • Imputation fills in missing values through a statistical model. It can use observed information efficiently, but its validity depends on the imputation model and its assumptions about the missing outcomes.
  • Bounds use minimal restrictions, such as a known outcome range, to show which target values remain compatible with the data. They avoid a prediction model but may be too wide to settle the clinical question.

A frequent mistake is to say, “The target mean is the mean among participants with recorded outcomes, because those are the people we can analyze.” That reasoning replaces the population in the estimand with a post-baseline subset selected by outcome recording. The correction is to state the target population and summary first, then describe the recorded subset as an incomplete source of information about that target.

A second distinction matters: an outcome that is defined but unrecorded is missing; an outcome that is not defined under the specified question is not merely a missing measurement. These require different conceptual decisions. Missing-data methods cannot, by themselves, decide what the target outcome should mean when it is undefined.

Key takeaway: Keep the estimand fixed while evaluating the observation process. The response indicator describes which outcome values are available; assumptions or additional information are needed to infer the target from the recorded values.

Check Your Understanding

Answer each question, then compare with the solutions.

  1. A target is the mean outcome for all participants under a specified strategy. Does analyzing only participants with recorded outcomes redefine that target, or change the information available for estimating it?
  2. In one arm, 70 of 100 outcomes are recorded and the observed mean is 5 points. Outcomes lie between 0 and 10. Calculate the range of possible target means using only these facts.
  3. Why does randomization of treatment assignment not, on its own, ensure that the observed-case mean estimates the all-participant mean?
  4. In one baseline group, no outcomes are recorded. Can conditional standardization estimate that group’s mean from its recorded outcomes? Name the relevant condition.

Solutions. (1) It changes the available information, not the defined target; the observed-case mean is directly about recorded participants. (2) The lower bound is \(\{(70)(5)+(30)(0)\}/100=3.5\) points, and the upper bound is \(\{(70)(5)+(30)(10)\}/100=6.5\) points. (3) Randomization concerns treatment assignment, not whether recording depends on outcome values; recording may select participants within each arm. (4) No. The group has zero recording probability, violating positivity, so its mean cannot be estimated from that group’s recorded outcomes.

Clinical Biostats